Jenean Spencer

1.4k total citations
31 papers, 951 citations indexed

About

Jenean Spencer is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Jenean Spencer has authored 31 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 15 papers in Infectious Diseases and 8 papers in Hepatology. Recurrent topics in Jenean Spencer's work include Hepatitis C virus research (8 papers), Influenza Virus Research Studies (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Jenean Spencer is often cited by papers focused on Hepatitis C virus research (8 papers), Influenza Virus Research Studies (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Jenean Spencer collaborates with scholars based in Australia, New Zealand and United Kingdom. Jenean Spencer's co-authors include Paul Roche, Geoffrey W. McCaughan, Yvonne E. Cossart, Megge Miller, John Kaldor, Noeline Latt, Gregory J. Dore, Keflemariam Yohannes, Philip J. Beeby and Edith Collins and has published in prestigious journals such as International Journal of Epidemiology, The Medical Journal of Australia and Journal of Gastroenterology and Hepatology.

In The Last Decade

Jenean Spencer

31 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenean Spencer Australia 18 606 473 219 145 60 31 951
Sema Mandal United Kingdom 20 739 1.2× 401 0.8× 287 1.3× 109 0.8× 87 1.4× 83 1.2k
Mustafa Sünbül Türkiye 20 533 0.9× 347 0.7× 430 2.0× 187 1.3× 69 1.1× 65 1.3k
Sabrina S. Plitt Canada 17 455 0.8× 172 0.4× 352 1.6× 179 1.2× 94 1.6× 56 918
Jodie Dionne‐Odom United States 16 390 0.6× 219 0.5× 232 1.1× 126 0.9× 99 1.6× 62 766
Dorcas Obiri‐Yeboah Ghana 18 652 1.1× 197 0.4× 354 1.6× 71 0.5× 160 2.7× 127 1.2k
Prabhu Gounder United States 15 395 0.7× 185 0.4× 217 1.0× 101 0.7× 53 0.9× 55 703
George Kamkamidze Georgia 15 394 0.7× 213 0.5× 248 1.1× 96 0.7× 80 1.3× 67 759
Helen Chun United States 17 432 0.7× 225 0.5× 365 1.7× 74 0.5× 125 2.1× 47 819
L. Salleras Spain 20 767 1.3× 201 0.4× 229 1.0× 62 0.4× 63 1.1× 70 1.2k
Liselotte van Asten Netherlands 19 612 1.0× 176 0.4× 396 1.8× 91 0.6× 53 0.9× 48 995

Countries citing papers authored by Jenean Spencer

Since Specialization
Citations

This map shows the geographic impact of Jenean Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenean Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenean Spencer more than expected).

Fields of papers citing papers by Jenean Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenean Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenean Spencer. The network helps show where Jenean Spencer may publish in the future.

Co-authorship network of co-authors of Jenean Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Jenean Spencer. A scholar is included among the top collaborators of Jenean Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenean Spencer. Jenean Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Rachael L., Haitham Tuffaha, Vendula Blaya‐Nováková, et al.. (2022). Approaches to prioritising research for clinical trial networks: a scoping review. Trials. 23(1). 1000–1000. 5 indexed citations
2.
Miller, Megge, Paul Roche, Keflemariam Yohannes, et al.. (2005). Australia's notifiable diseases status, 2003: Annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence. 29(1). 1–61. 66 indexed citations
3.
Robotin, Monica, Graham Tallis, David C. Coleman, et al.. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology. 19(3). 283–288. 41 indexed citations
4.
Miller, Megge, Paul Roche, & Jenean Spencer. (2004). Evaluation of Australia’s National Notifiable Disease Surveillance System. Communicable Diseases Intelligence. 28(3). 311–323. 32 indexed citations
5.
Yohannes, Keflemariam, et al.. (2004). Australia's notifiable diseases status, 2002: Annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence. 28(1). 6–68. 27 indexed citations
6.
Spencer, Jenean, et al.. (2003). Review of antenatal testing policies and practice for HIV and hepatitis C infection. Australian and New Zealand Journal of Public Health. 27(6). 614–619. 17 indexed citations
7.
Law, Matthew, Gregory J. Dore, Nicky Bath, et al.. (2003). Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology. 32(5). 717–724. 125 indexed citations
8.
Roche, Paul, Peter McIntyre, & Jenean Spencer. (2003). Pneumococcal disease in Australia: current status and future challenges. A report of the workshop held at the National Centre for Immunisation Research and Surveillance, 8-9 November, 2002. Communicable Diseases Intelligence. 27(1). 79–84. 1 indexed citations
9.
Yohannes, Keflemariam, Paul Roche, Alan Hampson, Megge Miller, & Jenean Spencer. (2003). Annual report of the National Influenza Surveillance Scheme, 2002. Communicable Diseases Intelligence. 27(2). 160–168. 32 indexed citations
10.
Roche, Paul, Jenean Spencer, & Stephen B. Lambert. (2003). Surveillance of viral pathogens in Australia: respiratory syncytial virus. Communicable Diseases Intelligence. 27(1). 117–122. 21 indexed citations
11.
Kaldor, John, et al.. (2002). Outcomes from the first two years of the Australian hepatitis C surveillance strategy. Communicable Diseases Intelligence. 26(1). 14–22. 6 indexed citations
12.
Roche, Paul, et al.. (2002). Laboratory Virology and Serology Reporting Scheme, 1991 to 2000. Communicable Diseases Intelligence. 26(3). 323–374. 13 indexed citations
13.
Lin, Ming‐Chih, Paul Roche, Jenean Spencer, et al.. (2002). Australia's notifiable diseases status, 2000: Annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence. 26(2). 118–203. 22 indexed citations
14.
Roche, Paul, Jenean Spencer, & Alan Hampson. (2002). Annual report of the National Influenza Surveillance Scheme, 2001. Communicable Diseases Intelligence. 26(2). 204–213. 3 indexed citations
15.
Lin, Ming‐Chih, Jenean Spencer, Paul Roche, & Moira McKinnon. (2002). Tuberculosis notifications in Australia, 2000. Communicable Diseases Intelligence. 26(2). 214–225. 7 indexed citations
16.
Roche, Peter J., Jenean Spencer, Angela Merianos, & Alan Hampson. (2001). Annual report of the National Influenza Surveillance Scheme, 2000. Communicable Diseases Intelligence. 25(3). 107–112. 3 indexed citations
17.
Latt, Noeline, Jenean Spencer, Philip J. Beeby, et al.. (2000). Hepatitis C in injecting drug‐using women during and after pregnancy. Journal of Gastroenterology and Hepatology. 15(2). 175–181. 26 indexed citations
18.
Butler, Tony, et al.. (1999). Seroprevalence of markers for hepatitis B, C and G in male and female prisoners - NSW, 1996. Australian and New Zealand Journal of Public Health. 23(4). 377–384. 54 indexed citations
19.
20.
Spencer, Jenean, Noeline Latt, Philip J. Beeby, et al.. (1997). Transmission of hepatitis C virus to infants of human immunodeficiency virus‐negative intravenous drug‐using mothers: rate of infection and assessment of risk factors for transmission. Journal of Viral Hepatitis. 4(6). 395–409. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sema Mandal Breakdown of academic impact, for papers by Mustafa Sünbül Breakdown of academic impact, for papers by Sabrina S. Plitt Breakdown of academic impact, for papers by Jodie Dionne‐Odom Breakdown of academic impact, for papers by Dorcas Obiri‐Yeboah Breakdown of academic impact, for papers by Prabhu Gounder Breakdown of academic impact, for papers by George Kamkamidze Breakdown of academic impact, for papers by Helen Chun Breakdown of academic impact, for papers by L. Salleras Breakdown of academic impact, for papers by Liselotte van Asten
Rankless by CCL
2026